Silk-based biospecimen stabilization for exposure assessment diagnostics
Award amount
$1,499,990Program and phase
SBIR · Phase IIAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- VAXESS TECHNOLOGIES INC
- Proposal award date
- 2017-09-15
- Contract end date
- 2019-08-31
- UEI
- HNLJN8YZPVJ3
- Solicitation number
- PA16-302
- Topic code
- 113
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development of a Needle Free Microarray Patch for Delivery of a GLP-1 Receptor Agonist
- Microarray Patch for Broadly Protective Seasonal Influenza Vaccination
- SBIR Phase I: At home, single dose mRNA vaccine patch (COVID-19)
- Improved Influenza Vaccine Efficacy Through Infection Mimicry
- Improved Influenza Vaccine Efficacy Through Infection Mimicry
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Development of an integrated smartphone-nanosensor platform for onsite biomonitoring of exposure to pesticides
- Novel sorbents for removal of PFAS from water
- A Personalized Digital Intervention Program to Reduce Exposure to Endocrine Disrupting Chemicals among a Child-Bearing Age Cohort
- Development and Evaluation of Rosette Array Technology for HumanNeurodevelopmental Toxicity Screening
- Wearable Multi-Gas Technologies for Monitoring Personal Air Quality
Research funding history
11 SBIR/STTR records share this UEI (2015–2024). Reported award amounts total $9,792,329. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation